Arix Bioscience
Overview
Arix Bioscience plc is a global healthcare and life science company supporting medical innovation. Headquartered in London and with an office in New York, Arix Bioscience sources, finances and builds world class healthcare and life science businesses addressing medical innovation at all stages of development. Operations are supported by privileged access to breakthrough academic science and strategic relationships with leading research accelerators and global pharmaceutical companies.\\Arix Bioscience plc is listed on the Main Market of the London Stock Exchange.\\For further information, please visit www.arixbioscience.com or connect with us on Twitter @arixbioscience\\
Investment Focus
- Innovative life science technologies
- Experienced management teams
- Strong intellectual property portfolios
- Clear regulatory pathways
- Scalable business models
- Potential for significant patient impact
- Alignment with Arix Bioscience's therapeutic focus areas
- Ability to attract additional funding
- Strong scientific evidence supporting the product
- Clear exit strategies for investors
Portfolio Companies
Get the full list of 54,000+ investors
Arix Bioscience and every other firm and angel in the database — as one spreadsheet you keep.
$19one-time payment · no subscription- All 54,000+ investors — VC firms, private equity, family offices and angels
- The key person to contact at each one, with their job title
- Their work email address
- Their phone number
- Their LinkedIn profile
- Delivered as a single .xlsx file — download it as many times as you like
Every profile on this site is one row of the file, with the contact details masked — browse a few before you buy.
Frequently asked questions about Arix Bioscience
What sectors does Arix Bioscience invest in?
Arix Bioscience invests in Healthcare, Digital Health, Pharmaceuticals, Medical Devices, Diagnostics and Biotechnology, and is based in London, England, United Kingdom. Arix Bioscience is listed as a venture capital in the ConnectSafely investor database.
What stage does Arix Bioscience invest at?
Arix Bioscience backs companies at Early Stage and Growth, writing cheques of 5M - 50M.
Which regions does Arix Bioscience invest in?
Arix Bioscience invests across United States, United Kingdom, Canada, Germany, Japan and Australia.
What companies has Arix Bioscience invested in?
Arix Bioscience's portfolio includes Kymab, Disc Medicine, Evommune, Optikira, Autolus Therapeutics, Harpoon Therapeutics, Pharmaxis and LogicBio Therapeutics.
How do I contact Arix Bioscience?
Arix Bioscience's contact details — including LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of the team.
Last updated · Source: ConnectSafely investor database
